Hailiang Hu

20PUBLICATIONS
92CO-AUTHORS
Predictive and prognostic markersElectrochemistryBiologically active moleculesMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 20, 2026
Glutamine synthesis pathway promotes the survival and recurrence of dormant tumor cells in prostate cancer.

|Jul 15, 2026
The Bidentate Adsorption Mode of Re-Ni Atomic Pairs Inducing the Ultralow Overpotential in CO2 Electroreduction.

|Jun 25, 2026
New Cytotoxic Anthraquinone Derivatives from a Deep-Sea-Derived Aspergillus sp. SCSIO 41331.

|May 29, 2026
Ferroptosis vulnerability of enzalutamide resistant prostate cancer conferred by ACSL4 overexpression and GPX4 antagonism.

|Mar 03, 2026
Covalent Organic Framework with Acid Precipitation Enhances Microprotein Enrichment and Discovery of Ferroptosis-Associated Microproteins.

Fengming Li, Jingchen Sui, Xiaoqian Wang

|Feb 27, 2026
UHRF1 regulates AR ubiquitination to promote the loss of AR signaling and enzalutamide resistance in progression of prostate cancer.

Yifan Zhang, Zhaojun Yu, Yadong Li

Pageof 4

Frequent Collaborators

3 joint publications

Xin Hong

3 joint publications

Qiang Wei

3 joint publications

Xian-Tao Zeng

2 joint publications

Lingfan Xu